Natalie Reizine is an Oncology physician affiliated with University of Illinois Chicago. OpenAlex indexes 62 publications with 680 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Sponsor: University of Chicago
- GU-01: Glycyrrhizin in Prostate Cancer
Sponsor: University of Illinois Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GenentechProgram year20253 paymentsResearch$30,238openpaymentsdata.cms.gov ↗
- Merck & Co.Program year20252 paymentsResearch$17,599openpaymentsdata.cms.gov ↗
- EMD SeronoProgram year20251 payment
Services and research payments matched to this physician's NPI in CMS Open Payments. Meals, travel and gifts are counted in the company total and not listed here. Research funding is listed under each investigator the record names.
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
John Daugirdas, MD
University of Illinois Chicago
Niranjan Karnik, MD
University of Illinois Chicago
Oana Danciu, MD
University of Illinois Chicago
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”